Author:
McClellan Mark,Brown Nancy,Califf Robert M.,Warner John J.
Abstract
Although advances in care have spurred improvements in cardiovascular outcomes, cardiovascular disease remains the leading cause of death in the United States and around the world. Previous declines in cardiovascular disease mortality have slowed and even reversed for certain demographics. Further concerns exist with regard to cardiovascular drug innovation, quality of care, and healthcare costs. The Value in Healthcare Initiative–Transforming Cardiovascular Care, a collaboration of the American Heart Association and Duke University, Robert J. Margolis, MD, Center for Health Policy, aims to increase access to and affordability of cardiovascular treatment and to decrease barriers to care. The following Call to Action describes trends in cardiovascular care, identifies gaps in areas of cardiovascular disease prevention and treatment, highlights challenges with medical product innovation, and finally, outlines a series of learning collaboratives that will aid in the development of road maps for transforming cardiovascular care.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference89 articles.
1. Mozaffarian D Benjamin E Go A Arnett D Blaha M Cushman M. Heart disease and stroke statistics–at-a-glance. December 2014. http://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_470704.pdf. Accessed July 16 2018.
2. Mortality in the United States, 2017.;Murphy SL;NCHS Data Brief,2018
3. A Tale of Coronary Artery Disease and Myocardial Infarction
4. Centers for Disease Control and Prevention. Underlying cause of death 1999–2017: CDC WONDER Online Database. https://wonder.cdc.gov/wonder/help/ucd.html. 2018. Accessed December 10 2018.
5. The Odyssey of TAVR from Concept to Clinical Reality
Cited by
175 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献